Profile data is unavailable for this security.
About the company
Orgenesis Inc. is a biotech company focused on cell and gene therapies (CGTs). The Company focuses on the development of autologous therapies that can be manufactured under processes and systems that are developed for each therapy using a closed and automated approach that is validated for compliant production near the patient for treatment of the patient at the point of care. It operates in two segments: Octomera LLC (Octomera segment) and therapies related activities (Therapies segment). The Octomera segment includes mainly point of care (POCare) services. The Therapies segment includes the Company’s therapeutic development operations. The POCare Services platform is utilized by parties, such as biotech companies and hospitals for the supply of their products. Octomera’s services include adapting the process to the platform and supplying the products; adaptation of automation and closed systems to serviced therapies, and contract research organization services for clinical trials.
- Revenue in USD (TTM)529.00k
- Net income in USD-45.66m
- Incorporated2008
- Employees146.00
- LocationOrgenesis Inc20271 Goldenrod LaneGERMANTOWN 20876United StatesUSA
- Phone+1 (480) 659-6404
- Websitehttps://www.orgenesis.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PetVivo Holdings Inc | 1.05m | -10.63m | 10.58m | 25.00 | -- | 10.34 | -- | 10.12 | -0.8694 | -0.8694 | 0.0842 | 0.06 | 0.3375 | 1.21 | 2.04 | 41,841.60 | -343.12 | -209.90 | -715.73 | -504.64 | 51.41 | 20.27 | -1,016.55 | -2,297.21 | 0.6169 | -2,268.84 | 0.1392 | -- | 693.46 | 260.32 | -73.83 | -- | 51.73 | -- |
| Biomerica Inc | 5.41m | -6.35m | 10.60m | 62.00 | -- | 1.36 | -- | 1.96 | -0.3789 | -0.3789 | 0.3224 | 0.4642 | 0.5827 | 2.28 | 5.74 | 87,180.80 | -68.45 | -43.55 | -83.73 | -50.32 | 11.41 | 15.75 | -117.46 | -55.86 | 3.37 | -- | 0.00 | -- | -71.71 | -0.8229 | -57.58 | -- | -9.76 | -- |
| Biotricity Inc | 11.63m | -15.39m | 12.99m | 55.00 | -- | -- | -- | 1.12 | -1.75 | -1.75 | 1.32 | -2.84 | 1.92 | 2.01 | 6.55 | 211,408.70 | -240.40 | -303.46 | -- | -- | 65.52 | 53.00 | -125.43 | -368.78 | 0.1012 | -0.5855 | -- | -- | 26.00 | -- | 35.36 | -- | -- | -- |
| ALR Technologies Inc | 9.49k | -8.00m | 13.18m | 6.00 | -- | -- | -- | 1,388.79 | -0.0147 | -0.0147 | 0.00002 | -0.0476 | 0.0358 | -- | -- | 1,581.67 | -3,015.28 | -12,861.64 | -- | -- | 62.49 | -- | -84,283.24 | -406,011.30 | -- | -0.8626 | -- | -- | -- | -- | -42.72 | -- | -- | -- |
| STRATA Skin Sciences Inc | 32.55m | -11.36m | 13.32m | 99.00 | -- | 1.41 | -- | 0.4094 | -0.3248 | -0.3248 | 0.9307 | 0.269 | 0.73 | 3.67 | 8.60 | 328,737.40 | -25.49 | -11.48 | -35.77 | -16.55 | 52.71 | 61.28 | -34.91 | -17.70 | 0.8376 | -3.90 | 0.6151 | -- | -7.75 | 2.24 | -95.17 | -- | 23.29 | -- |
| PAVmed Inc | 3.02m | -71.05m | 13.49m | 107.00 | -- | -- | -- | 4.47 | -9.08 | -9.08 | 0.3874 | -7.76 | 0.0588 | -- | 64.17 | 28,186.92 | -147.38 | -154.56 | -- | -1,152.82 | -126.09 | -- | -2,505.37 | -8,764.89 | 0.5301 | -8.32 | 1.82 | -- | 550.40 | -- | 25.76 | -- | 55.51 | -- |
| Dalrada Financial Corporation | 32.16m | -21.34m | 15.77m | 0.00 | -- | 1.79 | -- | 0.4905 | -0.2388 | -0.2388 | 0.3573 | 0.091 | 1.09 | 8.86 | 3.37 | -- | -75.10 | -80.63 | -239.06 | -- | 30.11 | 39.23 | -68.78 | -63.94 | 1.24 | -21.54 | 0.3452 | -- | 54.35 | -- | -43.94 | -- | -- | -- |
| Meihua International Medical Tech Co Ltd | 97.10m | 11.63m | 16.30m | 617.00 | 1.32 | 0.1048 | 1.35 | 0.1679 | 0.4856 | 0.4856 | 4.06 | 6.11 | 0.5788 | 46.66 | 1.31 | 157,372.60 | 6.91 | 12.26 | 8.13 | 15.05 | 34.19 | 38.14 | 11.94 | 15.47 | 5.21 | -- | 0.0475 | 0.00 | -6.05 | 5.10 | 86.22 | -5.56 | -9.16 | -- |
| Innovative Eyewear Inc | 1.39m | -7.20m | 16.61m | 11.00 | -- | 3.22 | -- | 11.94 | -0.6074 | -0.6074 | 0.1174 | 0.2948 | 0.2803 | 1.89 | 15.42 | 126,457.30 | -145.15 | -- | -168.75 | -- | -8.82 | -- | -517.88 | -- | 3.68 | -6,764.71 | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
| Orgenesis Inc | 529.00k | -45.66m | 17.22m | 146.00 | -- | -- | -- | 32.54 | -1.53 | -1.53 | 0.0174 | -0.8072 | 0.0101 | 49.69 | 0.049 | 3,623.29 | -98.12 | -- | -338.48 | -- | -660.87 | -- | -9,744.05 | -- | 0.0662 | -12.23 | -- | -- | -98.53 | -50.94 | -271.82 | -- | -17.71 | -- |
| QT Imaging Holdings Inc | 0.00 | -4.02m | 17.45m | -- | -- | 0.8027 | -- | -- | -0.3999 | -0.3999 | 0.00 | 1.01 | 0.00 | -- | -- | -- | -12.32 | -- | -16.60 | -- | -- | -- | -- | -- | -- | -- | 0.3042 | -- | -- | -- | -45.07 | -- | -- | -- |
| Agape ATP Corp | 1.37m | -2.39m | 20.13m | 21.00 | -- | 5.50 | -- | 14.70 | -0.0312 | -0.0312 | 0.018 | 0.0475 | 0.394 | 9.41 | 30.79 | 65,188.57 | -68.48 | -- | -94.72 | -- | 64.84 | -- | -173.78 | -- | 4.99 | -- | 0.0204 | -- | -22.92 | -- | -24.61 | -- | -- | -- |
| SANUWAVE Health Inc | 22.41m | -17.26m | 20.37m | 31.00 | -- | -- | -- | 0.909 | -0.0267 | -0.0267 | 0.0238 | -0.0417 | 1.10 | 3.60 | 7.50 | 722,838.70 | -84.54 | -136.54 | -- | -- | 71.63 | 69.13 | -77.00 | -189.60 | 0.1193 | 0.0192 | -- | -- | 21.84 | 61.61 | -150.72 | -- | -- | -- |
| Ekso Bionics Holdings Inc | 17.91m | -14.24m | 21.54m | 70.00 | -- | 1.53 | -- | 1.20 | -0.9685 | -0.9685 | 1.20 | 0.7765 | 0.5423 | 1.65 | 3.38 | 255,900.00 | -43.11 | -43.63 | -57.86 | -57.67 | 50.41 | 51.93 | -79.48 | -104.24 | 2.11 | -34.63 | 0.2937 | -- | 41.57 | 10.03 | -0.7825 | -- | 3.69 | -- |
| Neuraxis Inc | 2.30m | -14.39m | 21.81m | 19.00 | -- | -- | -- | 9.47 | -3.71 | -3.71 | 0.4945 | -0.4829 | 1.82 | 5.81 | 10.14 | 121,135.80 | -1,154.78 | -- | -- | -- | 87.72 | -- | -633.21 | -- | 0.1016 | -13.46 | -- | -- | -8.37 | -- | -163.78 | -- | -- | -- |
Data as of May 29 2024. Currency figures normalised to Orgenesis Inc's reporting currency: US Dollar USD
6.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 914.77k | 2.66% |
| Knoll Capital Management LPas of 31 Mar 2024 | 634.74k | 1.85% |
| Geode Capital Management LLCas of 31 Mar 2024 | 287.96k | 0.84% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 121.19k | 0.35% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 67.66k | 0.20% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 40.67k | 0.12% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 34.60k | 0.10% |
| Peilim Portfolio Management Co. Ltd.as of 31 Mar 2024 | 32.05k | 0.09% |
| Redwood Financial Network Corp.as of 31 Mar 2024 | 25.00k | 0.07% |
| Chapin Davis, Inc. (Investment Management)as of 31 Mar 2024 | 20.00k | 0.06% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
